Ultragenyx Pharmaceutical Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2025: -7.89

Ultragenyx Pharmaceutical Inc. Interest Coverage Ratio is -7.89 for the Trailing 12 Months (TTM) ending March 31, 2025, a -4.82% change year over year. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.
  • Ultragenyx Pharmaceutical Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2024 was -8.29, a -34.73% change year over year.
  • Ultragenyx Pharmaceutical Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2023 was -12.70, a -20.61% change year over year.
  • Ultragenyx Pharmaceutical Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2022 was -16.00, a 218.58% change year over year.
  • Ultragenyx Pharmaceutical Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2021 was -5.02, a -88.77% change year over year.
Key Data
Date Interest Coverage Ratio Return on Capital Employed (ROCE) Return on Equity (ROE) Return on Assets (ROA)